Year: 2026
Type: article
Abstract: In recent years, there has been active interest in studying the biological properties of cannabidiol, as evidenced by the number of inquiries in Science Direct: 763 references in 2024, 872 in 2025, and already 373 in the past months of 2026. The unique therapeutic capabilities of cannabidiol and its analogues have allowed regulators to lift restrictions on its circulation and medical use. The growing number of studies dedicated to cannabidiol enables a comprehensive elucidation of its therapeutic potential for treating various pathological conditions (epilepsy, pain syndrome, etc.). In this regard, a search of domestic and foreign literary sources was conducted by us with the aim of systematizing experimental and clinical data in the available literature on the biological and therapeutic effects of cannabidiol use. The search was performed in the electronic databases Cochrane, MEDSCAPE, Pubmed, eLibrary, CyberLeninka, and RusMed. During the review, data were found confirming the prospects of using cannabidiol as an anticonvulsant and analgesic agent. In this regard, further study of the chemical, physical and biochemical properties of cannabidiol and its synthetic analogs is relevant for the development of drugs.
DOI: 10.17816/phbn717303
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7233553064
